UNSPSC 51372104: Dihydrocodeine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51372104

Definition

This classification denotes an opioid receptor agonist and opioid with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N9I9HDB855, chemically known as 7, 8-dihydrocodeine but generally known as dihydrocodeine, which bears US NIH Compound Identifier 3063. European Medicines Agency schedules Dihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07138MIG. The term DIHYDROCODEINE is an International Non-Proprietary Name.

Read the full definition

World Health Organization schedules dihydrocodeine in its Anatomical Therapeutic Chemical (ATC) Classification. DIHYDROCODEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dihydrocodeine under HS 29391100 and SITC 54141. As of Q4 2014, DIHYDROCODEINE remains the US FDA Preferred Term for this commodity. Dihydrocodeine bears US NLM identifiers UMLS ID C0058056 and NCI Concept Code C84508. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)CCC2O.

About UNSPSC 51372104

UNSPSC 51372104 Dihydrocodeine is a Commodity code that state and local governments use to tag pharmaceutical procurement, though the recent solicitation activity under this code does not align with dihydrocodeine itself—the single identifiable opportunity concerns naloxone and drug deactivation systems rather than opioid pharmaceuticals. Seminole County, Florida posted an IFB in mid-2026 seeking annual procurement of naloxone and safe drug deactivation systems for community health delivery, suggesting the code captures a broader range of pharmaceutical and harm-reduction products than its nominal title reflects. State and local health departments, county community health systems, and public health agencies appear to be the primary issuing bodies soliciting under this code, though recent activity is sparse and the mismatch between the code name and the actual work being bought warrants clarification with procurement offices before pursuing opportunities tagged under 51372104.

The geographic spread of recent activity is limited; Seminole County represents the only identifiable recent opportunity in the source. Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement is fixed-fee, includes a two-year initial term with a one-year renewal option, and requires vendors to cover all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, complete E-Verify compliance, and submit bids electronically through the county's e-Procurement Portal. FEMA funding is mentioned as a potential source, which introduces federal compliance requirements including adherence to the Clean Air Act and Federal Water Pollution Control Act.

Quick answers

What is UNSPSC 51372104?

UNSPSC 51372104 is Dihydrocodeine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51372104?

UNSPSC 51372104 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51372104

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code